
Glow-up hype vs. safety: experts warn against unapproved injectable peptides
Influencers hype injectable peptides as a quick fix for acne, hair, pain and UTIs, but most are research-use only and sold online through unregulated channels. Benefits cited in marketing aren’t supported by robust clinical data, and contents, purity and safe dosing are unknown, posing risks such as skin cancers from tanning peptides, kidney issues and immune reactions. Even promising candidates like retatrutide require further trials to establish dosing and side effects, and using them without a doctor’s supervision can be dangerous. The piece cites experts from the Australian Medical Association and the University of Adelaide and notes a claim by US official RFK Jr. about approving peptide drugs for public sale.












